Cure for cancer: World’s top myeloma researcher: ‘We’re talking about curing blood cancer, unthinkable 20 years ago’ | Science & Tech

by admin
0 comment

A world-leading researcher on treatments for myeloma, a cancer of the blood, from the Castile and León region of Spain. Dr. Maria Victoria Mateos, 52, from the University of Salamanca Health Care Center said: have earned Recipient of the 2022 International Myeloma Society Bart Barlogie Clinical Investigator Award, presented at the group’s annual meeting in Los Angeles, California in late August. Mateos is also president of the Spanish Society of Hematology and Hematology and directs innovative therapies at the Salamanca Hospital.

The doctor, still overwhelmed by recent honors, insists that the hospital team and its patient care services be recognized, highlighting that it is the “work of the Spanish group” that has received international acclaim. .

Mateos explains that he has been studying myeloma since he completed his training in 2000 and was preparing for his PhD. it’s blood cancer It is the second most common blood disorder after lymphoma. As a result of progress that Mateos is proud of, myeloma is now successfully treated. [the disease] was inevitably fatalin the last few years we have been able to learn more about the disease and discover new drugs. According to the doctor, these drug advances, combined with the findings of the Spanish research group she is part of, are “a new and beneficial combination for patients. We are realistic about treating myeloma patients.” talking, but it was impossible [not so long] in front. “

We see older patients, so we appreciate the value in what we do. We offer quality and quantity of life.

Mateos explains that after entering medical school in Salamanca, he studied and specialized in hematology before he began writing his thesis on myeloma. As she was learning about the disease and writing her thesis, the institute discovered drugs that could help treat the disease, and she carried out “clinical studies” on which she built on her subsequent professional development and health care work. I did a test to make it work.

Mateos emphasizes that this progress has led to an increase in the number of patients diagnosed with myeloma. She now sees in her clinic many people who were diagnosed with the condition not so long ago, proving that they have been able to fight the disease for much longer than they did not long ago. “We see older patients, so we appreciate the value in what we do. We provide quality and quantity of life,” she said. say. Mateos praises new immunotherapeutic strategies and innovative treatments that act against tumor cells and are “very well tolerated” by patients.

Myeloma has a “constant incidence” of about 4 cases per 100,000 inhabitants each year, with about 2,000 cases detected annually, Mateos said. early diagnosis Enables detection of “new precancerous conditions”. These routine tests are essential to tackling this cancer and keeping patients on surveillance programs so they can receive appropriate care. It notes the need for additional funding and calls on the private sector to get involved through philanthropy.

Mateos said the main challenge facing the medical sector is the “delay” between a drug being discovered and reaching a patient. She admits the pandemic has slowed those processes down, but advocates speeding up procedures that will benefit thousands of patients now that the coronavirus has subsided.

The doctor argues that her award should also recognize equality in women’s access to research. It’s a worthwhile sacrifice and women can produce a lot of knowledge.”

You may also like

Leave a Comment